HALO
Halozyme Therapeutics, Inc. · Healthcare
President and CEO Helen Torley sold $1.1M of Halozyme Therapeutics, Inc.
Sold$1,065,743
$53.29Price
20,000Shares
−3%Stake
What HALO did after the filing
- The stock from Thu, Oct 10 open, $50.34
- −9.2%
- S&P 500, same days
- +3.1%
Measured over 30 trading days, to the Nov 21 close.
Traded Tue, Oct 8. Filed Wed, Oct 9, 5:39 PM ET, after the close. Returns use the Oct 10 open and the Nov 21 close. Not investment advice.